Tarsier Pharma Announces Publication of Review Article on Suppressing Inflammation for Treating Retinal Blinding Ocular Diseases, Highlighting dazdotuftide (TRS) as a Promising Therapeutic Candidate
/PRNewswire/ -- Tarsier Pharma Ltd., a late clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to...
Source: prnewswire.com